HEYL Trademark

Trademark Overview

On Thursday, July 5, 2012, a trademark application was filed for HEYL with the United States Patent and Trademark Office. The USPTO has given the HEYL trademark a serial number of 79123096. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Monday, April 8, 2024. This trademark is owned by HEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH & Co KG. The HEYL trademark is filed in the Pharmaceutical Products category with the following description:

Medicines, namely, antidotes, anti-rheumatics, and vitamin preparations for medical use; chemical products for medical and sanitary use, namely, chemical preparations for the treatment of poisonings by thallium, arsenic, heavy metals, and by radioactive isotopes; pharmaceutical preparations and drugs, namely, cytostatics and steroids; pharmaceutical preparations and drugs for the treatment of poisonings by thallium, arsenic, heavy metals, and by radioactive isotopes; medical plasters
heyl

General Information

Serial Number79123096
Word MarkHEYL
Filing DateThursday, July 5, 2012
Status706 - SECTION 71 ACCEPTED
Status DateMonday, April 8, 2024
Registration Number4430592
Registration DateTuesday, November 12, 2013
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 27, 2013

Trademark Statements

Description of MarkThe mark consists of "HEYL" in stylized lettering with a partial oval beneath the wording.
Goods and ServicesMedicines, namely, antidotes, anti-rheumatics, and vitamin preparations for medical use; chemical products for medical and sanitary use, namely, chemical preparations for the treatment of poisonings by thallium, arsenic, heavy metals, and by radioactive isotopes; pharmaceutical preparations and drugs, namely, cytostatics and steroids; pharmaceutical preparations and drugs for the treatment of poisonings by thallium, arsenic, heavy metals, and by radioactive isotopes; medical plasters
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 9, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHeyl Chemisch-pharmazeutische Fabrik GmbH & Co. KG
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressBerlin 10707
DE
Party NameHEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH & Co KG
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
Address14167 Berlin
DE
Party NameHEYL CHEMISCH-PHARMAZEUTISCHE FABRIK GMBH & Co KG
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
Address14167 Berlin
DE

Trademark Events

Event DateEvent Description
Monday, April 8, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Monday, April 8, 2024REGISTERED-SEC.71 ACCEPTED
Monday, April 8, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 31, 2023TEAS SECTION 71 RECEIVED
Thursday, March 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, November 12, 2022COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Thursday, June 2, 2022INTERNATIONAL REGISTRATION RENEWED
Friday, July 19, 2019NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Friday, July 19, 2019REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Friday, July 19, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, June 24, 2019TEAS SECTION 71 & 15 RECEIVED
Monday, November 12, 2018COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, March 2, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 27, 2015CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, April 3, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, February 26, 2014FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, February 26, 2014FINAL DISPOSITION PROCESSED
Wednesday, February 12, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, November 18, 2013REVIEW OF CORRESPONDENCE COMPLETE
Monday, November 18, 2013ASSIGNED TO PETITION STAFF
Tuesday, November 12, 2013REGISTERED-PRINCIPAL REGISTER
Friday, November 8, 2013TEAS POST PUBLICATION AMENDMENT RECEIVED
Tuesday, August 27, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 27, 2013PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, July 25, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, July 22, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 22, 2013EXAMINER'S AMENDMENT ENTERED
Monday, July 22, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, July 22, 2013EXAMINERS AMENDMENT E-MAILED
Monday, July 22, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, July 22, 2013ASSIGNED TO EXAMINER
Friday, July 19, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 19, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 11, 2013ASSIGNED TO LIE
Wednesday, July 10, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 5, 2013REFUSAL PROCESSED BY IB
Wednesday, January 16, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 16, 2013REFUSAL PROCESSED BY MPU
Tuesday, January 15, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 15, 2013APPLICATION FILING RECEIPT MAILED
Monday, January 14, 2013NON-FINAL ACTION WRITTEN
Wednesday, January 9, 2013ASSIGNED TO EXAMINER
Wednesday, January 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 3, 2013SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Related Keywords

heyl preparations medical namely metals arsenic thallium heavy radioactive drugs pharmaceutical